Items where authors include "Harland, M"

Article

Birkeälv, S, Harland, M, Matsuyama, LSAS et al. (15 more authors) (2023) Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. Journal of Pathology, 259 (1). pp. 56-68. ISSN 0022-3417

Simonin-Wilmer, I, Ossio, R, Leddin, EM et al. (14 more authors) (2022) Population-based analysis of POT1 variants in a cutaneous melanoma case–control cohort. Journal of Medical Genetics (JMG). ISSN 0022-2593

Castaneda-Garcia, C, Iyer, V, Nsengimana, J et al. (11 more authors) (2022) Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Human Molecular Genetics, 31 (17). pp. 2845-2856. ISSN 0964-6906

Pike, A, McKinley, C, Forrest, B et al. (19 more authors) (2022) COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria. The Lancet Haematology, 9 (8). E553-E556. ISSN 2352-3026

Davies, J, Muralidhar, S, Randerson-Moor, J et al. (15 more authors) (2022) Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity. Pigment Cell and Melanoma Research, 35 (2). pp. 252-267. ISSN 1755-1471

Landi, MT, Bishop, DT orcid.org/0000-0002-8752-8785, MacGregor, S et al. (158 more authors) (2020) Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature Genetics, 52 (5). pp. 494-504. ISSN 1061-4036

Juraleviciute, M, Pozniak, J, Nsengimana, J et al. (11 more authors) (2020) MX 2 is a novel regulator of cell cycle in melanoma cells. Pigment Cell & Melanoma Research, 33 (3). pp. 446-457. ISSN 1755-1471

Muralidhar, S, Filia, A, Nsengimana, J et al. (11 more authors) (2019) Vitamin D-VDR signaling inhibits Wnt/beta-catenin-mediated melanoma progression and promotes anti-tumor immunity. Cancer Research, 79 (23). pp. 5986-5998. ISSN 0008-5472

Thakur, R, Laye, JP, Lauss, M et al. (14 more authors) (2019) Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma. Clinical Cancer Research, 25 (24). pp. 7424-7435. ISSN 1078-0432

Filia, A, Droop, A, Harland, M et al. (10 more authors) (2019) High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material. Scientific Reports, 9 (1). ARTN: 8908. ISSN 2045-2322

Poźniak, J, Nsengimana, J, Laye, JP et al. (15 more authors) (2019) Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma. Cancer Research, 79 (10). pp. 2684-2696. ISSN 0008-5472

Taylor, NJ, Mitra, N, Goldstein, AM et al. (41 more authors) (2017) Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. Journal of Investigative Dermatology, 137 (12). pp. 2606-2612. ISSN 0022-202X

Jouenne, F, Chauvot de Beauchene, I, Bollaert, E et al. (33 more authors) (2017) Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma. Journal of Medical Genetics, 54 (9). pp. 607-612. ISSN 0022-2593

O'Shea, SJ orcid.org/0000-0002-1588-6022, Robles-Espinoza, C, McLellan, L et al. (10 more authors) (2017) A population-based analysis of germline BAP1 mutations in melanoma. Human Molecular Genetics, 26 (4). pp. 717-728. ISSN 0964-6906

Harland, M, Petljak, M, Robles-Espinoza, CD et al. (13 more authors) (2016) Germline TERT promoter mutations are rare in familial melanoma. Familial Cancer, 15 (1). pp. 139-144. ISSN 1389-9600

Law, M, Bishop, DT orcid.org/0000-0002-8752-8785, Lee, JE et al. (78 more authors) (2015) Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nature Genetics, 47 (9). pp. 987-995. ISSN 1061-4036